Through yearly updates, Materialise Mimics Innovation Suite (MIS) strives to position itself as a tool better equipped to meet today’s challenges surrounding the processing of sensitive information. With MIS 21.0, we present an entirely rewritten Anonymize tool, which offers users the option to de-identify sensitive information of data subjects according to the needs and requirements of their company or organization.
We’re pleased to introduce Nikhilesh Bappoo, our first prize winner of the Mimics Innovation Award 2017 APAC region. Nikhilesh developed a bioengineering framework to better understand how evolving blood flow affects the biomechanics of placental vasculature during pregnancy. In his groundbreaking research paper, he explores placental physiology by creating a 3D computational fluid dynamics (CFD) model of a rat’s placenta.
Global awareness of the benefits of 3D Printing has been growing steadily over the past years. In Asia, the technology is not as widespread compared to the United States or Europe - but that looks likely to change soon, with India heading the vanguard on the adoption of the technology in particular. The Amrita Institute of Medical Sciences is among the first hospitals in India to set up their own 3D printing lab, and will hopefully inspire surrounding countries to adopt the technology.
Recently, many hospitals have started making a shift, from using medical images primarily for diagnostic purposes, to integrating them in patient-specific surgical planning. This has created enormous advantages for hospitals and their patients, and is largely supported by the expanding role of the radiologist as imaging expert.
The Center for Structural Heart Disease at the Henry Ford Hospital under the leadership of Dr. William O’Neill is one of the leading Structural Heart programs. Dr. Dee Dee Wang, Director of Structural Heart Imaging at the Henry Ford Hospital and Medical Director of 3D Printing at the Henry Ford Innovations Institute recently spoke at the Materialise World Summit that took place in Brussels earlier this year. During her talk, she shared why 3D technology plays a critical role in their work on Structural Heart procedures and mostly Transcatheter Mitral Valve Replacement (TMVR) therapy.
In April 2017, a young patient with serious cardiac deformity was the happy recipient of a successful heart surgery. His case was very complex and the surgery entailed high risks. What makes this surgery even more special however, is that it was one of the first to be performed under the patronage of Little Hearts of China. This charity project brings in selected young patients with congenital heart disease (CHD) from the western region of China and offers them advanced medical care that would otherwise not be available locally.
In addition to its many other benefits, Medical 3D Printing has revolutionized how the pathology of a disease can be visualized. In a growing number of hospitals worldwide, it has earned its rightful place as standard procedure, for instance, in the placement of standard knee implants or in using cardiovascular models for preparing congenital heart defects surgery.
Cardiology has the distinction of being one of the earliest specializations in which patient-specific 3D anatomical models were implemented as part of treatment procedures. And although Medical 3D Printing has been used in the field for quite a few years already, much debate remains regarding which case should involve a 3D patient-specific model. It's a management decision that requires much thought and data. Until recently, literature on the use of 3D Printing in congenital heart disease (CHD) has been limited to anecdotal studies. This scientific publication has now given us more insight into the issue.
3D Printing is becoming progressively more accessible and is gaining momentum in several fields of medicine. From preoperative planning to developing innovative tools that enhance medical procedures, the endless possibilities in creating 3D anatomical models make the technology highly seductive in the quest to help patients.
The Children’s Memorial Health Institute is one of the largest specialist pediatric hospitals in Poland. Their medical team takes on highly rare and difficult cases of congenital heart disease, and innovative technologies are essential in solving these challenging cases.